Liver Transplantation Market Steers Towards a Valuation of US$ 2,653.4 Million by 2033, Charting a Course for Life-Saving Interventions

By 2033, the liver transplantation market is projected to be valued US$ 2,653.4 million. The market is projected to reach US$ 1,409.8 million by 2023. The liver transplantation market is anticipated to increase at a CAGR of 6.5% between 2023 and 2033 due to developments in the clinical domain.

It is observed that hepatitis C, cirrhosis, and chronic liver failure are the key reasons for liver transplantation. Over the years, there has been a great surge in end-stage liver disease in developed countries, such as the United States. Acute hepatic necrosis due to access alcohol consumption is another reason why the functionality of the liver gets adversely affected.

Request a Sample copy of this Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-1281

The liver transplantation market is anticipated to grow in the coming future, and the advancement of treatment techniques plays a prominent role. Reimbursement policies from the government and some private healthcare organizations have led to a surge in the liver transplantation market.

According to Weforum, 2022, around 130,000 transplants took place in 2020, out of which kidney was leading in organ transplants, tailed by liver and heart. Several companies developing surgery instruments and preservation techniques drive the liver transplant market.

For instance, in June 2022, a Swiss medical team devised a new method to minimize the waiting period for organ transplants. Moreover, the surgeons developed a new technology to keep a damaged liver alive for a few days. However, the team is still observing the patient and working on the same for promising growth.

“New storage techniques for damaged livers and effective research and development in stem cells, tissue engineering, and organogenesis can lessen the transplant waiting list.

Key Takeaways :

• The North American region showed a 29.2% share of the liver transplantation market.
• European nations also show promising market demand in the liver transplantation market, with a share of 20.7%.
• Based on treatment type, liver transplantation surgery dominates the liver transplantation market with a 61.1% global revenue share.
• According to the forecast, 51% of liver transplantation surgeries are done in hospitals, while the rest are done in ambulatory and adult liver transplantation centers.

Recent Developments Detected by FMI in the Liver Transplantation Market:

• In 2022, Jaslok Hospital and Research Center in Mumbai saved two lives with a single liver transplantation surgery. This transplantation surgery, also known as split cadaver liver donation surgery, is where the liver is split into two. It was then used by both an adult and a pediatric recipient simultaneously.

• In August 2022, Integrated Graphene, with a team of scientists, developed an electrochemical biosensor to detect biliary complications in donor livers. The device, Gii-Sens, can detect the quality of the liver before transplantation. It can prevent the development of biliary complications and match the donor-recipient for transplant. According to the makers of Gii-Sens, the device is portable, economical, and responds fast to point-of-care diagnostics.

Key Players:

• Allosource
• Conatus Pharmaceuticals Inc.
• Digna Biotech S.L.
• Dompe Farmaceutici S.p.A.
• Isogenis, Inc.
• RedHill Biopharma Ltd.
• Thompson Surgical
• Integra Life Sciences
• Baxter International Inc.
• XVIVO
• VirTech Bio
• Vital Therapies
• HepaTx
• Humedics

Unleash Potential: Craft Your Customized Report Now:
https://www.futuremarketinsights.com/customization-available/rep-gb-1281

Key Segments Profiled in the Global Liver Transplantation Market:

By Treatment Type:

• Liver Transplantation Surgery
• Post-Surgery Anti-Rejection Treatment
• Cyclosporine
• Tacrolimus
• Sirolimus Prednisone Azathioprine
• Mycophenolate Mofetil

By End Use:

• Hospitals
• Adult Liver Transplantation Centers
• Ambulatory Surgical Centers

By Region:

• North America
• Latin America
• Europe
• Asia Pacific
• The Middle East and Africa

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube